NEUROCRINE BIOSCIENCES INC Logo

NEUROCRINE BIOSCIENCES INC

Develops therapies for neurological, neuroendocrine, and neuropsychiatric disorders.

NBIX | US

Overview

Corporate Details

ISIN(s):
US64125C1099
LEI:
Country:
United States of America
Address:
6027 EDGEWOOD BEND COURT, 92130 SAN DIEGO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Neurocrine Biosciences is a biopharmaceutical company focused on neuroscience. For over three decades, it has been dedicated to discovering, developing, and commercializing treatments for patients with significant unmet needs in neurological, neuroendocrine, and neuropsychiatric disorders. The company's purpose is to relieve suffering by addressing complex and rare diseases with limited treatment options. Its portfolio includes approved medicines and a pipeline of potential therapies, leveraging an integrated understanding of neurology and endocrinology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NEUROCRINE BIOSCIENCES INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEUROCRINE BIOSCIENCES INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEUROCRINE BIOSCIENCES INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Mineralys Therapeutics, Inc. Logo
Developing targeted treatments for hypertension & CKD driven by elevated aldosterone.
United States of America
MLYS
MiNK Therapeutics, Inc. Logo
Developing allogeneic iNKT cell therapies for cancer and immune-mediated diseases.
United States of America
INKT
MIRA PHARMACEUTICALS, INC. Logo
Develops novel ketamine and THC analogs for neurologic and neuropsychiatric disorders.
United States of America
MIRA
Mirum Pharmaceuticals, Inc. Logo
Develops and commercializes therapies for rare, debilitating liver diseases in children and adults.
United States of America
MIRM
Mithra Pharmaceuticals S.A. Logo
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium
MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan
4595
MOA Life Plus Co. Ltd. Logo
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea
142760
Moberg Pharma Logo
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden
MOB
Mochida Pharmaceutical Co.,Ltd. Logo
An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.
Japan
4534
Moderna, Inc. Logo
Pioneering mRNA science to create transformative medicines and vaccines for diverse diseases.
United States of America
MRNA

Talk to a Data Expert

Have a question? We'll get back to you promptly.